June 24, 2024
Research led by the University of Cincinnati sheds new light on the role of the TGF-β signaling pathway in the brain to maintain balance and prevent inflammation and cognitive deficits.
October 6, 2022
The University of Cincinnati is committing $12 million to grow inclusive excellence by leveraging diverse perspectives to advance innovation, creativity and complex problem solving in biomedical research. The new program, FIRST+ Lives Here for Urban Health, aligns with the National Institutes of Health’s FIRST (Faculty Institutional Recruitment for Sustainable Transformation) Program and advances the university’s Next Lives Here strategic direction.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.
October 17, 2022
Treatments for pulmonary arterial hypertension (PAH) — a type of high blood pressure that affects arteries in the lungs and in the heart — have improved significantly over the past 15 to 20 years and researchers at the University of Cincinnati have been at the forefront of those improvements. The result of a series of studies UC researchers were part of have allowed new medications to come to market for patients with PAH.
September 21, 2022
UC is one of 36 sites part of the GRADE study comparing different diabetes medicines. The study is going to be published in the New England Journal of Medicine.
January 29, 2024
Researchers are passionate about their fields of study for a variety of reasons. For Satish Madala, his focus on asthma is deeply personal. “This is my ‘close to heart’ project because I came to this research area mainly because of my childhood asthma,” says Madala, PhD, of the UC College of Medicine.
June 14, 2024
Dr. Vincent Martin, professor in the UC College of Medicine, presents research at the annual American Headache Society meeting showing that as temperatures rise so do the chances for migraine attacks.
April 11, 2024
The University of Cincinnati Cancer Center is one of 25 sites across the country hosting the SHIP trial testing whether samples self-collected by patients for HPV testing are as accurate and effective as clinic-collected samples.